Works matching IS 17574676 AND DT 2019 AND VI 11 AND IP 5
Results: 13
Efficacy of simultaneous VEGF‐A/ANG‐2 neutralization in suppressing spontaneous choroidal neovascularization.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 5, p. N.PAG, doi. 10.15252/emmm.201810204
- By:
- Publication type:
- Article
Requirement for YAP1 signaling in myxoid liposarcoma.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 5, p. 1, doi. 10.15252/emmm.201809889
- By:
- Publication type:
- Article
A KDM6A–KLF10 reinforcing feedback mechanism aggravates diabetic podocyte dysfunction.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 5, p. 1, doi. 10.15252/emmm.201809828
- By:
- Publication type:
- Article
Inhibition of proteasome rescues a pathogenic variant of respiratory chain assembly factor COA7.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 5, p. 1, doi. 10.15252/emmm.201809561
- By:
- Publication type:
- Article
Non‐canonical cMet regulation by vimentin mediates Plk1 inhibitor–induced apoptosis.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 5, p. N.PAG, doi. 10.15252/emmm.201809960
- By:
- Publication type:
- Article
Gender and sex—time to bridge the gap.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 5, p. 1, doi. 10.15252/emmm.201910668
- By:
- Publication type:
- Article
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 5, p. N.PAG, doi. 10.15252/emmm.201910666
- By:
- Publication type:
- Article
International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 5, p. 1, doi. 10.15252/emmm.201910486
- By:
- Publication type:
- Article
Myxoid liposarcoma: it's a hippo's world.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 5, p. 1, doi. 10.15252/emmm.201910470
- By:
- Publication type:
- Article
Stop wasting protein—Proteasome inhibition to target diseases linked to mitochondrial import.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 5, p. 1, doi. 10.15252/emmm.201910441
- By:
- Publication type:
- Article
Anti‐VEGF‐A/ANG2 combotherapy limits pathological angiogenesis in the eye: a replication study.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 5, p. N.PAG, doi. 10.15252/emmm.201910362
- By:
- Publication type:
- Article
miR‐181a/b downregulation exerts a protective action on mitochondrial disease models.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 5, p. 1, doi. 10.15252/emmm.201708734
- By:
- Publication type:
- Article
DNA methylation inhibitor attenuates polyglutamine‐induced neurodegeneration by regulating Hes5.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 5, p. 1, doi. 10.15252/emmm.201708547
- By:
- Publication type:
- Article